V. Mutua, “Tocilizumab in addition to standard of care in the management of COVID-19: a meta-analysis of RCTs”, Acta Biomed, vol. 93, no. 1, p. e2022014, Mar. 2022, doi: 10.23750/abm.v93i1.12208.